Ulrich Ohnsorge

Title: Ulrich Ohnsorge: Innovator in Cardiac and Circulatory Disorder Treatments

Introduction

Ulrich Ohnsorge is a notable inventor based in Goenheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that address cardiac and circulatory disorders. With a total of 3 patents to his name, Ohnsorge's work is pivotal in advancing medical treatments.

Latest Patents

Ohnsorge's latest patents include the innovative compound 4-hydroxy-1,2-benzisothiazole and its derivatives. This compound serves as an intermediate for new drugs that are beneficial in treating cardiac and circulatory disorders. Another significant patent involves amino derivatives of 4-hydroxy-1,2-benzisothiazole, which includes new aminopropanol derivatives and their pharmaceutical formulations. These formulations are designed for the treatment and prophylaxis of cardiac and circulatory disorders.

Career Highlights

Ulrich Ohnsorge is associated with BASF Aktiengesellschaft, a leading company in the chemical industry. His work at BASF has allowed him to focus on innovative solutions that have a direct impact on healthcare. His research and development efforts have led to advancements in drug formulations that are crucial for patient care.

Collaborations

Ohnsorge has collaborated with esteemed colleagues such as Helmut Hagen and Fritz-Frieder Frickel. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the pharmaceutical field.

Conclusion

Ulrich Ohnsorge's contributions to the development of treatments for cardiac and circulatory disorders highlight his importance as an inventor in the pharmaceutical industry. His innovative patents and collaborations continue to pave the way for advancements in medical science.